Perspective Therapeutics (CATX) Notes Payables (2023 - 2026)

Perspective Therapeutics has disclosed Notes Payables across 4 years of filings, most recently posting $56000.0 for Q1 2026.

• Notes Payables for Q1 2026 came in at $56000.0, up 5.66% year-over-year; the trailing twelve-month figure through Mar 2026 was $56000.0 (up 5.66% YoY), and the FY2025 annual result was $56000.0, up 7.69% from the prior year.
• Notes Payables came in at $56000.0 for Q1 2026 at Perspective Therapeutics, roughly flat from $56000.0 in the prior quarter.
• In the past five years, Notes Payables ranged from a high of $1.8 million in Q2 2023 to a low of $49000.0 in Q4 2023.
• The 4-year median for Notes Payables is $54000.0 (2024), against an average of $316846.2.
• Across the five-year window, Notes Payables plunged 97.06% in 2024 and climbed 7.84% in 2025, its largest moves.
• Perspective Therapeutics' Notes Payables stood at $49000.0 in 2023, then grew by 6.12% to $52000.0 in 2024, then grew by 7.69% to $56000.0 in 2025, then changed by 0.0% to $56000.0 in 2026.
• The last three Notes Payables figures came in at $56000.0 (Q1 2026), $56000.0 (Q4 2025), and $55000.0 (Q3 2025), per Business Quant data.